INTERNATIONAL PATENT: DAEWOONG PHARMACEUTICAL CO., LTD., 주식회사 대웅제약 FILES APPLICATION FOR "METHOD FOR PREPARATION OF 1-((3S,4R)-3-((2-((1-ETHYL-1H-PYRAZOL-4-YL)AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)OXY)-4-FLUOROPIPERIDIN-1-YL)PROP-2-EN-1-ONE AND INTERMEDIATE COMPOUNDS THEREOF"

GENEVA, June 18 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14, Jeyakgongdan 4-gil, Hyangnam-eup,Hwaseong-si,Gyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2024/019811) for "METHOD FOR PREPARATION OF 1-((3S,4R)-3-((2-((1-ETHYL-1H-PYRAZOL-4-YL)AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)OXY)-4-FLUOROPIPERIDIN-1-YL)PROP-2-EN-1-ONE, AND INTERMEDIATE COMPOUNDS THEREOF" on Dec 05, 2024. With publication no. WO/2025/121899, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the Intern...